MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 355 filers reported holding MEDIVATION INC in Q3 2015. The put-call ratio across all filers is 0.57 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $883,000 | -81.6% | 14,660 | -85.9% | 0.04% | -79.4% |
| Q1 2016 | $4,789,000 | -48.7% | 104,160 | -52.6% | 0.21% | -38.2% |
| Q3 2015 | $9,331,000 | -21.8% | 219,555 | +110.1% | 0.35% | -13.1% |
| Q2 2015 | $11,932,000 | +5323.6% | 104,487 | +6003.2% | 0.40% | +4875.0% |
| Q1 2015 | $220,000 | -97.0% | 1,712 | -97.7% | 0.01% | -97.1% |
| Q4 2014 | $7,336,000 | +223.6% | 73,657 | +221.1% | 0.27% | +161.0% |
| Q3 2014 | $2,267,000 | +60.3% | 22,939 | +25.0% | 0.10% | +41.9% |
| Q2 2014 | $1,414,000 | +265.4% | 18,356 | +204.7% | 0.07% | +252.4% |
| Q1 2014 | $387,000 | – | 6,024 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,484,101 | $148,897,000 | 79.45% |
| BB BIOTECH AG | 1,449,706 | $86,895,000 | 4.73% |
| SECTORAL ASSET MANAGEMENT INC | 1,013,529 | $60,751,000 | 2.92% |
| Orbimed Advisors | 2,284,500 | $136,933,000 | 2.44% |
| Archipel Asset Management AB | 191,016 | $11,449,000 | 2.35% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 147,060 | $8,815,000 | 1.43% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 450,000 | $26,973,000 | 1.32% |
| QVT Financial LP | 305,128 | $18,289,000 | 1.24% |
| Bain Capital Public Equity Management, LLC | 825,687 | $49,492,000 | 1.24% |
| Tradeworx Inc. | 44,484 | $2,666,000 | 1.22% |